You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia (CLL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

Recruiting
  • Chronic Lymphocytic Leukemia
    • Granada, Spain
    • +4 more
    Nov 8, 2023

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 20, 2023

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Salt Lake City, Utah
      Huntsman Cancer Institute at University of Utah
    Jan 17, 2023

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Zanubrutinib Pill
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Dec 6, 2022

    Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

    Not yet recruiting
    • Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Leukemia (SLL)
    • Evanston, Illinois
    • +7 more
    Sep 9, 2022

    Orelabrutinib in the Treatment of CLL/SLL

    Not yet recruiting
    • CLL/SLL
      • (no location specified)
      Jul 26, 2023

      Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

      Completed
      • Lymphoid Leukemia
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Jan 30, 2023

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Not yet recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 10, 2023

      Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Mantle Cell Lymphoma
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Aug 22, 2022

      Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Stamford, Connecticut
      • +4 more
      Dec 2, 2022

      Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
        • Be'er Sheva, HaDarom, Israel
        • +12 more
        Sep 9, 2022

        Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Questionnaires
        • Fit Bit
        • Houston, Texas
          M D Anderson Cancer Center
        May 18, 2023

        Biomarker for Infection Risk in CLL and MM

        Not yet recruiting
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Screening
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        May 3, 2023

        Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

        Completed
        • Leukemia, Lymphocytic, Chronic
        • Dresden, Germany
        • +10 more
        Jan 13, 2023

        Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
        • +2 more
        Aug 19, 2022

        Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

        Not yet recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • +5 more
        • Routine care as per site standard.
        • (no location specified)
        Sep 15, 2023